Shoulder Innovations (SI): Gilde Healthcare sells shares, holds 10.7% stake
According to a Form 10-K filed May 13, 2026, Gilde Healthcare and related Dutch entities hold 2,212,207 shares of Shoulder Innovations, Inc. common stock, or 10.7% based on 20,738,226 shares outstanding as of May 6, 2026. The filing also reports open-market sales in late July to early August 2026, including 99,812 shares sold Aug. 4 at a weighted average $22.77.
How this was made
The 30-second read
Why it matters
Traders may monitor SI for follow-on selling pressure or changes in control dynamics, but there is no new operational catalyst in the excerpt.
Market read
This is a shareholder-structure datapoint: a 10.7% holder remains invested while having sold shares recently, which may influence near-term positioning rather than fundamentals.
What to watch
The article does not quantify remaining selling plans, lockups, or whether other insiders/holders are changing positions, limiting signal strength.
Background
The text is a filing summary of an Amendment No. 1 to a major-holder report (Schedule 13D), updating beneficial ownership and listing recent open-market sales by Gilde Healthcare and related entities.
Ticker impact
The article summarizes a Schedule 13D amendment showing Gilde Healthcare holds 10.7% of Shoulder Innovations and sold shares in early August.
Likely limited, with any effect more about sentiment and float/supply than earnings power.
The disclosure is about beneficial ownership and timing/size of sales, not guidance, contracts, or business performance. Still, a 10.7% holder selling can affect trading flows and positioning.
Market effects
No direct sector read-through; this is a shareholder-structure update rather than a product or regulatory development.
None indicated.
None indicated.
Counterpoint
The sales could be routine rebalancing or tax-related, so the market may overreact to the headline stake reduction.
Key entities
- public_companyShoulder Innovations, Inc.
Subject of the major-holder update; beneficial ownership is reported at 10.7% with disclosed open-market sales.
- major_holderGilde Healthcare
Record holder of the reported shares and disclosed seller in the July 30 to August 6 window.
